Literature DB >> 1629854

Chronic adult T-cell leukaemia/lymphoma presenting with cutaneous manifestations.

W G Phillips1, J A Langtry, C Formstone, A M Taylor, J R Marsden.   

Abstract

Entities:  

Mesh:

Year:  1992        PMID: 1629854      PMCID: PMC1293552     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  6 in total

1.  Prodromal cutaneous lesions in adult T-cell leukaemia/lymphoma.

Authors:  A Pagliuca; H Williams; J Salisbury; G J Mufti
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

2.  Variation in the clinical courses of adult T-cell leukemia.

Authors:  F Kawano; K Yamaguchi; H Nishimura; H Tsuda; K Takatsuki
Journal:  Cancer       Date:  1985-02-15       Impact factor: 6.860

3.  Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus.

Authors:  K Kinoshita; T Amagasaki; S Ikeda; J Suzuyama; K Toriya; K Nishino; M Tagawa; M Ichimaru; S Kamihira; Y Yamada
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

4.  Cutaneous type of adult T cell leukemia/lymphoma in a French West Indian woman. Clonal rearrangement of T-cell receptor beta and gamma genes and monoclonal integration of HTLV-I proviral DNA in the skin infiltrate.

Authors:  A Gessain; I Moulonguet; B Flageul; P Perrin; C Capesius; M F D'Agay; C Gisselbrecht; F Sigaux; J Civatte
Journal:  J Am Acad Dermatol       Date:  1990-11       Impact factor: 11.527

5.  Nonspecific integration of the HTLV provirus genome into adult T-cell leukaemia cells.

Authors:  M Seiki; R Eddy; T B Shows; M Yoshida
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

6.  Examination of HTLV-I integration in the skin lesions of various types of adult T-cell leukemia (ATL): independence of cutaneous-type ATL confirmed by Southern blot analysis.

Authors:  N Dosaka; T Tanaka; Y Miyachi; S Imamura; A Kakizuka
Journal:  J Invest Dermatol       Date:  1991-02       Impact factor: 8.551

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.